2019
DOI: 10.1016/j.vaccine.2019.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(35 citation statements)
references
References 41 publications
0
34
0
1
Order By: Relevance
“…Therefore, no predominant IgG isotype or Th immune response was correlated with protective efficacy of each FHBP formulation in either the mono or multisubunit vaccines. In some studies, IgG2 isotype or Th1 response has been observed to confer protection against leptospirosis [34,52,53]. However, Th2 is conventionally believed to be responsible for protection against extracellular pathogens including leptospires in spite of their transient tissue invasion [54].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, no predominant IgG isotype or Th immune response was correlated with protective efficacy of each FHBP formulation in either the mono or multisubunit vaccines. In some studies, IgG2 isotype or Th1 response has been observed to confer protection against leptospirosis [34,52,53]. However, Th2 is conventionally believed to be responsible for protection against extracellular pathogens including leptospires in spite of their transient tissue invasion [54].…”
Section: Discussionmentioning
confidence: 99%
“…Further investigations using different combinations of these subunit vaccines including all FHBPs, except LigAc, are required to determine the crucial components. Chimeric vaccines containing fusion of protective FHBPs will be a promising strategy to deliver the vaccine antigens as previously reported [49,52,53].…”
Section: Discussionmentioning
confidence: 99%
“…Manilae strain L495 wild-type and mutant strains were cultivated in DMCs as previously described [42,43,108]. Briefly, DMCs were prepared with 9-10 mls of EMJH medium Table. Copy numbers were calculated using internal standard curves (10 7-10 1 copies) generated using purified amplicons for perRA, perRB, LIMLP18590 and LIMLP04825 and then normalized against lipL32 [179]. The standard curve for lipL32 was generated using a copy of the lipL32 amplicon cloned into pCR2.1-TOPO plasmid (Invitrogen).…”
Section: Generation Of Host-adapted Leptospiresmentioning
confidence: 99%
“…The variable carboxy-terminal domain 7-13 of leptospiral immunoglobulin-like protein A (LigAc) is currently the most promising antigen for leptospirosis vaccines [5][6][7]. Different types and formulations of LigAc-based vaccines, including DNA [8,9], recombinant single subunit [5][6][7], multisubunit [10,11], chimeric [12][13][14] vaccines, delivery systems [15], and adjuvants [16,17], have been tested for their efficacy in animal models. However, all these strategies were unable to completely prevent Leptospira renal colonization and pathological changes.…”
Section: Introductionmentioning
confidence: 99%